Pfizer Inc
NYSE: PFE
$26.18
-$0.25 (-1.0%)
Real Time Data Delayed 15 Min.
PFE Articles
The short interest data have been released for the August 31 settlement date, and for the selected pharmaceutical stocks, short interest is mixed.
Published:
thinkstockSeptember 10, 2015: Markets opened lower on Thursday after a rather lackluster performance in Asia’s equity markets and more of the same in Europe. Initial claims for unemployment...
Published:
Last Updated:
thinkstockSeptember 8, 2015: Markets opened higher on Tuesday following reports that the Chinese government would pump more liquidity into the equity market. China’s trade data was mixed: the...
Published:
Last Updated:
As in all outbreaks of volatility, there are islands of relative stability drowned out by the companies causing the loudest turbulence.
Published:
thinkstockAugust 31 2015: Markets opened lower on Monday, but even a massive rally in crude oil couldn’t keep the bears at bay. A somewhat vague bulletin from OPEC and an EIA report that June...
Published:
Last Updated:
thinkstockAugust 28, 2015: Markets opened lower on Friday, and except for a brief visit above the break-even line, the blue chips traded lower all day. Crude oil settled at $45.22, up more than 6% on...
Published:
Last Updated:
The S&P 500 is adding two new components: Activision Blizzard and United Continental.
Published:
If investors have dry powder or have raised cash by selling higher beta momentum stocks, these stocks may make good sense to rotate to now.
Published:
The August 14 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short interest is mixed.
Published:
ThinkstockAt a time when there is pressure on how large US companies are making domestic or overseas acquisitions are coming under more scrutiny, Pfizer Inc. (NYSE:PFE) announced on Monday that the...
Published:
A new research note from Jefferies lists stocks that could have meaningful events soon. The stocks in some cases have sold off significantly, and the analysts view fundamental downside as limited.
Published:
The short interest data have been released for the July 31 settlement date, and for most of the selected pharmaceutical stocks, short interest decreased.
Published:
24/7 Wall St. maintains on its watch list a slew of defensive dividend stocks that investors flock to during periods of uncertainty. The trick is to know which companies are appropriate at a given...
Published:
thinkstockAugust 6, 2015: Markets opened higher again on Thursday but not by much and equities quickly turned south and remained in the red for the rest of the day. The report on new claims for...
Published:
Last Updated:
24/7 Wall St. screened the Merrill Lynch health care universe and found four pharmaceutical stocks rated Buy with outstanding short-term and long-term potential.
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.